These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
666 related articles for article (PubMed ID: 12604411)
21. TRAIL and apoptosis induction by TNF-family death receptors. Wang S; El-Deiry WS Oncogene; 2003 Nov; 22(53):8628-33. PubMed ID: 14634624 [TBL] [Abstract][Full Text] [Related]
22. Effect of Bax deficiency on death receptor 5 and mitochondrial pathways during endoplasmic reticulum calcium pool depletion-induced apoptosis. He Q; Montalbano J; Corcoran C; Jin W; Huang Y; Sheikh MS Oncogene; 2003 May; 22(17):2674-9. PubMed ID: 12730681 [TBL] [Abstract][Full Text] [Related]
23. Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review). Gupta S Int J Oncol; 2003 Jan; 22(1):15-20. PubMed ID: 12469180 [TBL] [Abstract][Full Text] [Related]
24. Fas and other cell death signaling pathways. Depraetere V; Golstein P Semin Immunol; 1997 Apr; 9(2):93-107. PubMed ID: 9194220 [TBL] [Abstract][Full Text] [Related]
25. Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: potential targets for apoptosis induction. Koornstra JJ; Jalving M; Rijcken FE; Westra J; Zwart N; Hollema H; de Vries EG; Hofstra RW; Plukker JT; de Jong S; Kleibeuker JH Eur J Cancer; 2005 May; 41(8):1195-202. PubMed ID: 15911244 [TBL] [Abstract][Full Text] [Related]
26. Modulation of TRAIL signaling for cancer therapy. Fulda S; Debatin KM Vitam Horm; 2004; 67():275-90. PubMed ID: 15110182 [TBL] [Abstract][Full Text] [Related]
27. Epidermal growth factor and trail interactions in epithelial-derived cells. Gibson SB Vitam Horm; 2004; 67():207-27. PubMed ID: 15110179 [TBL] [Abstract][Full Text] [Related]
28. Cyclooxygenase-2 inhibition sensitizes human colon carcinoma cells to TRAIL-induced apoptosis through clustering of DR5 and concentrating death-inducing signaling complex components into ceramide-enriched caveolae. Martin S; Phillips DC; Szekely-Szucs K; Elghazi L; Desmots F; Houghton JA Cancer Res; 2005 Dec; 65(24):11447-58. PubMed ID: 16357153 [TBL] [Abstract][Full Text] [Related]
29. Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5. Horak P; Pils D; Kaider A; Pinter A; Elandt K; Sax C; Zielinski CC; Horvat R; Zeillinger R; Reinthaller A; Krainer M Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8585-91. PubMed ID: 16361541 [TBL] [Abstract][Full Text] [Related]
30. Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-alpha. Herr I; Posovszky C; Di Marzio LD; Cifone MG; Boehler T; Debatin KM Oncogene; 2000 Aug; 19(37):4255-62. PubMed ID: 10980599 [TBL] [Abstract][Full Text] [Related]
31. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. Grell M; Zimmermann G; Gottfried E; Chen CM; Grünwald U; Huang DC; Wu Lee YH; Dürkop H; Engelmann H; Scheurich P; Wajant H; Strasser A EMBO J; 1999 Jun; 18(11):3034-43. PubMed ID: 10357816 [TBL] [Abstract][Full Text] [Related]
33. Involvement of tumor necrosis factor-alpha receptor 1 and tumor necrosis factor-related apoptosis-inducing ligand-(TRAIL) receptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantation. Tashiro H; Itamoto T; Ohdan H; Arihiro K; Tateaki Y; Nakahara H; Ochi M; Hino H; Mizunuma K; Hara H; Tokita D; Onoe T; Ishiyama K; Mitsuta H; Sugino K; Asahara T Transpl Int; 2004 Nov; 17(10):626-33. PubMed ID: 15502938 [TBL] [Abstract][Full Text] [Related]
34. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells. Sylvester PW; Shah S Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643 [TBL] [Abstract][Full Text] [Related]
35. Apo2L/TRAIL and its death and decoy receptors. LeBlanc HN; Ashkenazi A Cell Death Differ; 2003 Jan; 10(1):66-75. PubMed ID: 12655296 [TBL] [Abstract][Full Text] [Related]
36. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector. Rubinchik S; Yu H; Woraratanadharm J; Voelkel-Johnson C; Norris JS; Dong JY Cancer Gene Ther; 2003 Nov; 10(11):814-22. PubMed ID: 14605667 [TBL] [Abstract][Full Text] [Related]
38. Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling. El-Deiry WS Cell Death Differ; 2001 Nov; 8(11):1066-75. PubMed ID: 11687885 [TBL] [Abstract][Full Text] [Related]
39. Death receptors in chemotherapy and cancer. Debatin KM; Krammer PH Oncogene; 2004 Apr; 23(16):2950-66. PubMed ID: 15077156 [TBL] [Abstract][Full Text] [Related]